234 related articles for article (PubMed ID: 18653781)
1. Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization.
Grant M; Alturaihi H; Jaquet P; Collier B; Kumar U
Mol Endocrinol; 2008 Oct; 22(10):2278-92. PubMed ID: 18653781
[TBL] [Abstract][Full Text] [Related]
2. Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly.
Gatto F; Biermasz NR; Feelders RA; Kros JM; Dogan F; van der Lely AJ; Neggers SJ; Lamberts SW; Pereira AM; Ferone D; Hofland LJ
Eur J Endocrinol; 2016 May; 174(5):651-62. PubMed ID: 26888629
[TBL] [Abstract][Full Text] [Related]
3. Selective Interactions of Mouse Melanocortin Receptor Accessory Proteins with Somatostatin Receptors.
Wang M; Xu J; Lei XW; Zhang C; Liu SY; Jin LN; Zhang C
Cells; 2022 Jan; 11(2):. PubMed ID: 35053382
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin and its receptor family.
Patel YC
Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.
Shimon I
Endocrine; 2003 Apr; 20(3):265-9. PubMed ID: 12721506
[TBL] [Abstract][Full Text] [Related]
6. Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.
Tulipano G; Stumm R; Pfeiffer M; Kreienkamp HJ; Höllt V; Schulz S
J Biol Chem; 2004 May; 279(20):21374-82. PubMed ID: 15001578
[TBL] [Abstract][Full Text] [Related]
7. Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion.
Ren SG; Taylor J; Dong J; Yu R; Culler MD; Melmed S
J Clin Endocrinol Metab; 2003 Sep; 88(9):4239-45. PubMed ID: 12970293
[TBL] [Abstract][Full Text] [Related]
8. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).
Pfeiffer M; Koch T; Schröder H; Klutzny M; Kirscht S; Kreienkamp HJ; Höllt V; Schulz S
J Biol Chem; 2001 Apr; 276(17):14027-36. PubMed ID: 11134004
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S
J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919
[TBL] [Abstract][Full Text] [Related]
10. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
Jaquet P; Saveanu A; Gunz G; Fina F; Zamora AJ; Grino M; Culler MD; Moreau JP; Enjalbert A; Ouafik LH
J Clin Endocrinol Metab; 2000 Feb; 85(2):781-92. PubMed ID: 10690891
[TBL] [Abstract][Full Text] [Related]
11. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.
Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991
[TBL] [Abstract][Full Text] [Related]
12. Agonist-biased trafficking of somatostatin receptor 2A in enteric neurons.
Zhao P; Canals M; Murphy JE; Klingler D; Eriksson EM; Pelayo JC; Hardt M; Bunnett NW; Poole DP
J Biol Chem; 2013 Sep; 288(36):25689-25700. PubMed ID: 23913690
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.
Shimon I; Taylor JE; Dong JZ; Bitonte RA; Kim S; Morgan B; Coy DH; Culler MD; Melmed S
J Clin Invest; 1997 Feb; 99(4):789-98. PubMed ID: 9045884
[TBL] [Abstract][Full Text] [Related]
15. Activation of nuclear factor {kappa}B by somatostatin type 2 receptor in pancreatic acinar AR42J cells involves G{alpha}14 and multiple signaling components: a mechanism requiring protein kinase C, calmodulin-dependent kinase II, ERK, and c-Src.
Liu AM; Wong YH
J Biol Chem; 2005 Oct; 280(41):34617-25. PubMed ID: 16115892
[TBL] [Abstract][Full Text] [Related]
16. BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
Jaquet P; Gunz G; Saveanu A; Barlier A; Dufour H; Taylor J; Dong J; Kim S; Moreau JP; Culler MD
J Endocrinol Invest; 2005; 28(11 Suppl International):21-7. PubMed ID: 16625841
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20.
Tallent M; Liapakis G; O'Carroll AM; Lolait SJ; Dichter M; Reisine T
Neuroscience; 1996 Apr; 71(4):1073-81. PubMed ID: 8684611
[TBL] [Abstract][Full Text] [Related]
18. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
[TBL] [Abstract][Full Text] [Related]
19. C-tail mediated modulation of somatostatin receptor type-4 homo- and heterodimerizations and signaling.
Somvanshi RK; Billova S; Kharmate G; Rajput PS; Kumar U
Cell Signal; 2009 Sep; 21(9):1396-414. PubMed ID: 19426801
[TBL] [Abstract][Full Text] [Related]
20. Characterization of agonist-dependent somatostatin receptor subtype 2 trafficking in neuroendocrine cells.
Alshafie W; Pan YE; Kreienkamp HJ; Stroh T
Endocrine; 2020 Sep; 69(3):655-669. PubMed ID: 32383089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
